{"title":"用v指数定量莫西沙星给药时心室复极异质性","authors":"M. Rivolta, L. Mainardi, R. Sassi","doi":"10.1109/ESGCO.2014.6847580","DOIUrl":null,"url":null,"abstract":"Drug-induced alterations of ventricular heterogeneity must be limited to avoid induction of lethal ventricular arrhythmias. In here, a new parameter called V-index, able to measure the standard deviation of myocites' repolarization times, was evaluated after moxifloxacin administration. 24-h Holter ECGs of 68 healthy subjects enrolled for a thorough QT study were retrospectively analyzed. The placebo and active-comparator (moxifloxacin) arms were considered. The standard QT interval (Fridericia's correction) was included as well, for a direct comparison. V-index and QT increased along with the drug's serum concentration and were statistically different from values in the placebo arm (p<;0.05). Peak values were reached 5 hours after administration (QTc: 428.77 ± 25.17 ms at 5h vs 418.08 ± 23.37 ms at 0h; V-index: 31.67 ± 11.01 ms at 5h vs 27.72 ± 7.59 at 0h) and both were statistically different from predose (p<;0.05). Interestingly, V-index displayed a larger percent variation (27.72% ± 34.06% vs 2.93% ± 2.81%; p<;0.05).","PeriodicalId":385389,"journal":{"name":"2014 8th Conference of the European Study Group on Cardiovascular Oscillations (ESGCO)","volume":"51 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2014-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Quantification of ventricular repolarization heterogeneity during moxifloxacin administration using V-index\",\"authors\":\"M. Rivolta, L. Mainardi, R. Sassi\",\"doi\":\"10.1109/ESGCO.2014.6847580\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Drug-induced alterations of ventricular heterogeneity must be limited to avoid induction of lethal ventricular arrhythmias. In here, a new parameter called V-index, able to measure the standard deviation of myocites' repolarization times, was evaluated after moxifloxacin administration. 24-h Holter ECGs of 68 healthy subjects enrolled for a thorough QT study were retrospectively analyzed. The placebo and active-comparator (moxifloxacin) arms were considered. The standard QT interval (Fridericia's correction) was included as well, for a direct comparison. V-index and QT increased along with the drug's serum concentration and were statistically different from values in the placebo arm (p<;0.05). Peak values were reached 5 hours after administration (QTc: 428.77 ± 25.17 ms at 5h vs 418.08 ± 23.37 ms at 0h; V-index: 31.67 ± 11.01 ms at 5h vs 27.72 ± 7.59 at 0h) and both were statistically different from predose (p<;0.05). Interestingly, V-index displayed a larger percent variation (27.72% ± 34.06% vs 2.93% ± 2.81%; p<;0.05).\",\"PeriodicalId\":385389,\"journal\":{\"name\":\"2014 8th Conference of the European Study Group on Cardiovascular Oscillations (ESGCO)\",\"volume\":\"51 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-05-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2014 8th Conference of the European Study Group on Cardiovascular Oscillations (ESGCO)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1109/ESGCO.2014.6847580\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2014 8th Conference of the European Study Group on Cardiovascular Oscillations (ESGCO)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/ESGCO.2014.6847580","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
摘要
药物引起的心室异质性改变必须加以限制,以避免诱发致死性室性心律失常。在本研究中,我们评估了莫西沙星给药后心肌复极时间标准差的新参数v指数。回顾性分析68名健康受试者的24小时动态心电图,进行全面的QT研究。安慰剂组和活性比较剂(莫西沙星)组被考虑。标准QT间期(Fridericia校正)也包括在内,以便进行直接比较。v指数和QT随药物血清浓度升高而升高,与安慰剂组差异有统计学意义(p<;0.05)。给药后5h达到峰值(QTc: 5h 428.77±25.17 ms vs 0h 418.08±23.37 ms;v指数:5h时为31.67±11.01 ms, 0h时为27.72±7.59 ms),与给药前比较差异有统计学意义(p< 0.05)。有趣的是,v指数表现出更大的百分比差异(27.72%±34.06% vs 2.93%±2.81%);p < 0.05)。
Quantification of ventricular repolarization heterogeneity during moxifloxacin administration using V-index
Drug-induced alterations of ventricular heterogeneity must be limited to avoid induction of lethal ventricular arrhythmias. In here, a new parameter called V-index, able to measure the standard deviation of myocites' repolarization times, was evaluated after moxifloxacin administration. 24-h Holter ECGs of 68 healthy subjects enrolled for a thorough QT study were retrospectively analyzed. The placebo and active-comparator (moxifloxacin) arms were considered. The standard QT interval (Fridericia's correction) was included as well, for a direct comparison. V-index and QT increased along with the drug's serum concentration and were statistically different from values in the placebo arm (p<;0.05). Peak values were reached 5 hours after administration (QTc: 428.77 ± 25.17 ms at 5h vs 418.08 ± 23.37 ms at 0h; V-index: 31.67 ± 11.01 ms at 5h vs 27.72 ± 7.59 at 0h) and both were statistically different from predose (p<;0.05). Interestingly, V-index displayed a larger percent variation (27.72% ± 34.06% vs 2.93% ± 2.81%; p<;0.05).